Maynard Um
-
-
-
-
-
-
-
Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Ibtrozi Progress
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Nuvation Bio Inc (NUVB)
-
-
-
-
-
-
-
Nuvation Bio Inc (NUVB) PT Lowered to $17 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Nuvation Bio Inc (NUVB)
-
-
-
-
-
-
-
Nuvation Bio begins phase 3 trial of safusidenib for brain cancer
-
-
-
-
-
-
-
Nuvation Bio Inc. (NUVB) Reports In-Line Q2 EPS
-
-
-
-
-
-
-
Nuvation Bio (NUVB) said granted FDA approval for Ibtrozi for non-small cell lung cancer
-
416,253 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

